Intellia Therapeutics, Inc. (NTLA) › Total AssetsIntellia Therapeutics, Inc. (NTLA) — Total AssetsAnnual figures by fiscal year, from SEC filings.2015: $82.14M2016: $298.97M2017: $376.24M2018: $347.31M2019: $334.28M2020: $676.32M2021: $1.29B2022: $1.52B2023: $1.30B2024: $1.19B2025: $842.13M$842.13M2015Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$842.13M-29.3%2024$1.19B-8.5%2023$1.30B-14.4%2022$1.52B+17.4%2021$1.29B+91.4%2020$676.32M+102.3%2019$334.28M-3.8%2018$347.31M-7.7%2017$376.24M+25.8%2016$298.97M+264.0%2015$82.14M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share